← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Tymora Analytical Operations, Llc
West Lafayette, IN
$7,981,081
Total funding
16
Grants
Funding over time
peak $1.1M · FY2011–25$2M$1.5M$1M$500K$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$7,211,133 · 14
NSF$769,948 · 2
By mechanism
R44$4,091,262 · 3
R41$1,712,837 · 5
R43$1,407,034 · 6
—$769,948 · 2
Investigators at Tymora Analytical Operations, Llc
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
Validation and clinicaldevelopment of plasma EV protein biomarkers for minimally-invasive detection of Alzheimersdisease$854,102
R44 · FY2025 · AG
Validation and clinicaldevelopment of plasma EV protein biomarkers for minimally-invasive detection of Alzheimersdisease$815,028
R44 · FY2024 · AG
Development of non-invasive biomarker discovery and diagnostics approach for bladder cancer based on urine proteome and phosphoproteome$700,000
R44 · FY2021 · CA
SBIR Phase II: Development of Novel Dendrimer-based Technologies for Phosphorylation Analyses$619,948
· FY2013 · TIP
Development of non-invasive biomarker discovery and diagnostics approach for bladder cancer based on urine proteome and phosphoproteome$600,000
R44 · FY2020 · CA
Multiplexed detection and imaging of protein phosphorylation based on soluble nanopolymers$451,538
R44 · FY2015 · CA
Multiplexed detection and imaging of protein phosphorylation based on soluble nanopolymers$445,595
R44 · FY2016 · CA
Metal ion-functionalized soluble nanopolymers: A new analytical platform for plas$328,449
R41 · FY2015 · GM
Metal ion-functionalized soluble nanopolymers: A new analytical platform for plas$312,537
R41 · FY2014 · GM
Development of companion diagnostics for dasatinib-based personalized therapy for T-ALL$310,000
R43 · FY2021 · CA
Developing high throughput measurement of thiopurine in DNA by mass spectrometry$299,975
R41 · FY2020 · GM
Proteomic differentiation of leukemia cells based on multiplexed arrays and mass$299,967
R41 · FY2013 · GM
Development of lavage EV protein biomarkers for minimally-invasive detection of endometrial cancer$290,000
R43 · FY2022 · CA
Developing EV surface proteins as biosignatures for Alzheimer's disease (AD)$244,909
R41 · FY2020 · AG
Developing novel RPPA for the detection of metastatic prostate cancer$225,000
R41 · FY2016 · CA
Development of non-invasive biomarker discovery and diagnostics approach for bladder cancer based on urine proteome and phosphoproteome$224,999
R44 · FY2019 · CA
Development of non-invasive research and diagnostics platform for Alzheimer's disease based on plasma exosomes$215,369
R43 · FY2019 · AG
Developing gel-based platform for quantitative phosphoproteomics$150,000
R43 · FY2015 · GM
SBIR Phase I: Development of Novel Dendrimer-based Technologies for Phosphorylation Analyses$150,000
· FY2011 · TIP
Novel soluble nanopolymers for enrichment of low abundant phosphoproteins$150,000
R43 · FY2012 · CA